Report cover image

Global Retinoid Treatment for Skin Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 196 Pages
SKU # APRC20360204

Description

Summary

According to APO Research, the global Retinoid Treatment for Skin market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Retinoid Treatment for Skin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Retinoid Treatment for Skin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Retinoid Treatment for Skin market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Retinoid Treatment for Skin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Retinoid Treatment for Skin market include Almirall, Bausch Health, Galderma, HUAPONT, Lion, Mayne Pharma, Sine Pharma, Sun Pharma and GlaxoSmithKline, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Retinoid Treatment for Skin, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Retinoid Treatment for Skin, also provides the value of main regions and countries. Of the upcoming market potential for Retinoid Treatment for Skin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Retinoid Treatment for Skin revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Retinoid Treatment for Skin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Retinoid Treatment for Skin company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Retinoid Treatment for Skin Segment by Company

Almirall
Bausch Health
Galderma
HUAPONT
Lion
Mayne Pharma
Sine Pharma
Sun Pharma
GlaxoSmithKline
Mylan
Teva
Retinoid Treatment for Skin Segment by Type

OTC
Prescription Medicine
Retinoid Treatment for Skin Segment by Application

Topical
Oral
Retinoid Treatment for Skin Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Retinoid Treatment for Skin status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Retinoid Treatment for Skin key companies, revenue, market share, and recent developments.
3. To split the Retinoid Treatment for Skin breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Retinoid Treatment for Skin market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Retinoid Treatment for Skin significant trends, drivers, influence factors in global and regions.
6. To analyze Retinoid Treatment for Skin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Retinoid Treatment for Skin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Retinoid Treatment for Skin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Retinoid Treatment for Skin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Retinoid Treatment for Skin industry.
Chapter 3: Detailed analysis of Retinoid Treatment for Skin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Retinoid Treatment for Skin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Retinoid Treatment for Skin in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Retinoid Treatment for Skin Market Size, 2020 VS 2024 VS 2031
1.3 Global Retinoid Treatment for Skin Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Retinoid Treatment for Skin Market Dynamics
2.1 Retinoid Treatment for Skin Industry Trends
2.2 Retinoid Treatment for Skin Industry Drivers
2.3 Retinoid Treatment for Skin Industry Opportunities and Challenges
2.4 Retinoid Treatment for Skin Industry Restraints
3 Retinoid Treatment for Skin Market by Company
3.1 Global Retinoid Treatment for Skin Company Revenue Ranking in 2024
3.2 Global Retinoid Treatment for Skin Revenue by Company (2020-2025)
3.3 Global Retinoid Treatment for Skin Company Ranking (2023-2025)
3.4 Global Retinoid Treatment for Skin Company Manufacturing Base and Headquarters
3.5 Global Retinoid Treatment for Skin Company Product Type and Application
3.6 Global Retinoid Treatment for Skin Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Retinoid Treatment for Skin Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Retinoid Treatment for Skin Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Retinoid Treatment for Skin Market by Type
4.1 Retinoid Treatment for Skin Type Introduction
4.1.1 OTC
4.1.2 Prescription Medicine
4.2 Global Retinoid Treatment for Skin Sales Value by Type
4.2.1 Global Retinoid Treatment for Skin Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Retinoid Treatment for Skin Sales Value by Type (2020-2031)
4.2.3 Global Retinoid Treatment for Skin Sales Value Share by Type (2020-2031)
5 Retinoid Treatment for Skin Market by Application
5.1 Retinoid Treatment for Skin Application Introduction
5.1.1 Topical
5.1.2 Oral
5.2 Global Retinoid Treatment for Skin Sales Value by Application
5.2.1 Global Retinoid Treatment for Skin Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Retinoid Treatment for Skin Sales Value by Application (2020-2031)
5.2.3 Global Retinoid Treatment for Skin Sales Value Share by Application (2020-2031)
6 Retinoid Treatment for Skin Regional Value Analysis
6.1 Global Retinoid Treatment for Skin Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Retinoid Treatment for Skin Sales Value by Region (2020-2031)
6.2.1 Global Retinoid Treatment for Skin Sales Value by Region: 2020-2025
6.2.2 Global Retinoid Treatment for Skin Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Retinoid Treatment for Skin Sales Value (2020-2031)
6.3.2 North America Retinoid Treatment for Skin Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Retinoid Treatment for Skin Sales Value (2020-2031)
6.4.2 Europe Retinoid Treatment for Skin Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Retinoid Treatment for Skin Sales Value (2020-2031)
6.5.2 Asia-Pacific Retinoid Treatment for Skin Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Retinoid Treatment for Skin Sales Value (2020-2031)
6.6.2 South America Retinoid Treatment for Skin Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Retinoid Treatment for Skin Sales Value (2020-2031)
6.7.2 Middle East & Africa Retinoid Treatment for Skin Sales Value Share by Country, 2024 VS 2031
7 Retinoid Treatment for Skin Country-level Value Analysis
7.1 Global Retinoid Treatment for Skin Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Retinoid Treatment for Skin Sales Value by Country (2020-2031)
7.2.1 Global Retinoid Treatment for Skin Sales Value by Country (2020-2025)
7.2.2 Global Retinoid Treatment for Skin Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.3.2 USA Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.4.2 Canada Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.6.2 Germany Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.7.2 France Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.7.3 France Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.9.2 Italy Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.10.2 Spain Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.11.2 Russia Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.14.2 China Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.14.3 China Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.15.2 Japan Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.17.2 India Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.17.3 India Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.18.2 Australia Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.22.2 Chile Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.24.2 Peru Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.26.2 Israel Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.27.2 UAE Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.29.2 Iran Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Retinoid Treatment for Skin Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Retinoid Treatment for Skin Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Retinoid Treatment for Skin Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Almirall
8.1.1 Almirall Comapny Information
8.1.2 Almirall Business Overview
8.1.3 Almirall Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.1.4 Almirall Retinoid Treatment for Skin Product Portfolio
8.1.5 Almirall Recent Developments
8.2 Bausch Health
8.2.1 Bausch Health Comapny Information
8.2.2 Bausch Health Business Overview
8.2.3 Bausch Health Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.2.4 Bausch Health Retinoid Treatment for Skin Product Portfolio
8.2.5 Bausch Health Recent Developments
8.3 Galderma
8.3.1 Galderma Comapny Information
8.3.2 Galderma Business Overview
8.3.3 Galderma Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.3.4 Galderma Retinoid Treatment for Skin Product Portfolio
8.3.5 Galderma Recent Developments
8.4 HUAPONT
8.4.1 HUAPONT Comapny Information
8.4.2 HUAPONT Business Overview
8.4.3 HUAPONT Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.4.4 HUAPONT Retinoid Treatment for Skin Product Portfolio
8.4.5 HUAPONT Recent Developments
8.5 Lion
8.5.1 Lion Comapny Information
8.5.2 Lion Business Overview
8.5.3 Lion Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.5.4 Lion Retinoid Treatment for Skin Product Portfolio
8.5.5 Lion Recent Developments
8.6 Mayne Pharma
8.6.1 Mayne Pharma Comapny Information
8.6.2 Mayne Pharma Business Overview
8.6.3 Mayne Pharma Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.6.4 Mayne Pharma Retinoid Treatment for Skin Product Portfolio
8.6.5 Mayne Pharma Recent Developments
8.7 Sine Pharma
8.7.1 Sine Pharma Comapny Information
8.7.2 Sine Pharma Business Overview
8.7.3 Sine Pharma Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.7.4 Sine Pharma Retinoid Treatment for Skin Product Portfolio
8.7.5 Sine Pharma Recent Developments
8.8 Sun Pharma
8.8.1 Sun Pharma Comapny Information
8.8.2 Sun Pharma Business Overview
8.8.3 Sun Pharma Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.8.4 Sun Pharma Retinoid Treatment for Skin Product Portfolio
8.8.5 Sun Pharma Recent Developments
8.9 GlaxoSmithKline
8.9.1 GlaxoSmithKline Comapny Information
8.9.2 GlaxoSmithKline Business Overview
8.9.3 GlaxoSmithKline Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.9.4 GlaxoSmithKline Retinoid Treatment for Skin Product Portfolio
8.9.5 GlaxoSmithKline Recent Developments
8.10 Mylan
8.10.1 Mylan Comapny Information
8.10.2 Mylan Business Overview
8.10.3 Mylan Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.10.4 Mylan Retinoid Treatment for Skin Product Portfolio
8.10.5 Mylan Recent Developments
8.11 Teva
8.11.1 Teva Comapny Information
8.11.2 Teva Business Overview
8.11.3 Teva Retinoid Treatment for Skin Revenue and Gross Margin (2020-2025)
8.11.4 Teva Retinoid Treatment for Skin Product Portfolio
8.11.5 Teva Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.